Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 5, 2024 | Lykos Therapeutics | $100.0M Series A | Suprotik Basu | Eir Therapeutics, KittyHawk Ventures, Satori Neuro, Alexandra M. Cohen, The Joe and Sandy Samberg Foundation, True Ventures, Unlikely Collaborators, Vine Ventures |
| Sep 1, 2021 | Delix Therapeutics | $70.0M Series A | OMX Ventures, Andrew Levin | Vasudev Bailey, Artis Ventures (AV), B Capital Group, Negev Capital, Prithvi Ventures, PsyMed Ventures, RA Capital, Satori Capital, Trucks Venture Capital, What If Ventures, Apeiron Investment Group, Casa Verde Capital, Dolby Family Ventures, Noetic Fund, Ocama Partners, Palo Santo, Presight Capital, R^2, re.Mind Capital, Saya Bio, Vertical Venture Partners, WPSS |
| Dec 23, 2020 | Beckley Psytech | $18.8M Other Equity | — | Noetic Fund |
| Feb 1, 2019 | atai Life Sciences | $13.0M Series B | Michael Auerbach | Endeavor8, Endeavor Venture Funds, Negev Capital, Northpond Ventures, Wilbur-Ellis [Cavallo], David Ebsworth, Peter Keen, Efrem Kamen, Apeiron Investment Group |